share_log

HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $14

HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $14

HC Wainwright & Co.維持對ProPhase Labs的買入,將目標價下調至14美元
Benzinga ·  2023/05/12 09:00

HC Wainwright & Co. analyst Yi Chen maintains ProPhase Labs (NASDAQ:PRPH) with a Buy and lowers the price target from $15 to $14.

HC Wainwright & Co. 分析師陳毅維持ProPhase Labs(納斯達克股票代碼:PRPH)的買入,並將目標股價從15美元下調至14美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論